JoaoA Mde AndradeMD

PubMed

• Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.
  Joao A de Andrade, Tejaswini Kulkarni, Megan L Neely, Anne S Hellkamp, Amy Hajari Case, Daniel A Culver, Kalpalatha Guntupalli, Shaun Bender, Craig S Conoscenti, Lauri...> ;Respiratory Research. 2022 Jan 7
• 3 citations
  Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: Data from the IPF-PRO registry.
  Joao A. de Andrade, Tejaswini Kulkarni, Megan L. Neely, Anne S. Hellkamp, Amy Hajari Case, Kalpalatha K. Guntupalli, Shaun Bender, Craig S Conoscenti, Laurie D. Snyder...> ;Respiratory Medicine. 2021 Sep 29
• 34 citations
  Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETO...
  Solange Peters, J.-L. Pujol, Urania Dafni, M. Dómine, Sanjay Popat, M. Reck, J. Andrade, A. Becker, Denis Moro-Sibilot, Alessandra Curioni-Fontecedro, O. Molinier, Kri...> ;Annals of Oncology. 2021 Sep 23
• 21 citations
  Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative.
  Gary M. Hunninghake, Jonathan G. Goldin, Michael A. Kadoch, Jonathan A. Kropski, Ivan O. Rosas, Athol U. Wells, Ruchi Yadav, Howard M. Lazarus, Fereidoun G. Abtin, Tam...> ;Chest. 2021 Jun 28
• 1 citations
  Idiopathic pulmonary fibrosis: exploring the clinical and economic implications of the evolving treatment landscape.
  Joao A. de Andrade, Gary M Owens, Leslie Tolle> ;The American Journal of Managed Care. 2021 May 1
• 7 citations
  Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib
  Franck Rahaghi, John A. Belperio, John E. Fitzgerald, Mridu Gulati, Robert W. Hallowell, Kristin B. Highland, Tristan J. Huie, Hyun J Kim, Martin Kolb, Joseph A. Lasky...> ;Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine. 2021 Mar 30
• 57 citations
  Citrullinated vimentin mediates development and progression of lung fibrosis
  Fu Jun Li, Ranu Surolia, Huashi Li, Zheng Wang, Gang Liu, Tejaswini Kulkarni, Adriana V.F. Massicano, James A. Mobley, Santanu Mondal, Joao A. de Andrade, Scott A. Coo...> ;Science Translational Medicine. 2021 Mar 17
• 19 citations
  The Pulmonary Fibrosis Foundation Patient Registry. Rationale, Design, and Methods.
  Bonnie R Wang, Rex Edwards, Elizabeth A. Freiheit, Yicheng Ma, Cindy Burg, Joao A. de Andrade, Lisa Lancaster, Kathleen O. Lindell, Steven D. Nathan, Ganesh Raghu, Kev...> ;Annals of the American Thoracic Society. 2020 Dec 1
• 7 citations
  Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fi...
  Franck Rahaghi, Zeenat Safdar, Anne Brown, Joao A. de Andrade, Kevin R. Flaherty, Robert J. Kaner, Christopher S. King, Maria L. Padilla, Imre Noth, Mary Beth Scholand...> ;BMC Pulmonary Medicine. 2020 Jul 14
• 14 citations
  Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry
  Laurie D. Snyder, Chris Mosher, Colin Holtze, Lisa Lancaster, Kevin R. Flaherty, Imre Noth, Megan L. Neely, Anne S. Hellkamp, Shaun Bender, Craig S Conoscenti, Joao A....> ;BMJ Open Respiratory Research. 2020 Jul 1
• 11 citations
  Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Re...
  Yanni Fan, Shaun Bender, Craig S Conoscenti, Linda Davidson-Ray, Patricia A. Cowper, Scott M. Palmer, Joao A. de Andrade, Ipf-Pro Registry investigators> ;Chest. 2020 Jun 1
• 11 citations
  Assessment of viral RNA in idiopathic pulmonary fibrosis using RNA-seq
  Qinyan Yin, Michael J. Strong, Yan Zhuang, Erik K. Flemington, Naftali Kaminski, Joao A. de Andrade, Joseph A. Lasky> ;BMC Pulmonary Medicine. 2020 Apr 3
• 10 citations
  The senescence-associated matricellular protein CCN1 in plasma of human subjects with idiopathic pulmonary fibrosis.
  Tejaswini Kulkarni, Ashish Kurundkar, Young-il Kim, Joao A. de Andrade, Tracy Luckhardt, Victor J. Thannickal> ;Respiratory Medicine. 2020 Jan 1
• 49 citations
  Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry
  Jamie L. Todd, Megan L. Neely, Robert Overton, Katey Durham, Mridu Gulati, Howard J. Huang, Jesse Roman, L. Kristin Newby, Kevin R. Flaherty, Richard Vinisko, Yi Liu, ...> ;Respiratory Research. 2019 Oct 22
• 27 citations
  Decrements of body mass index are associated with poor outcomes of idiopathic pulmonary fibrosis patients.
  Tejaswini Kulkarni, Kaiyu Yuan, Thi K. Tran-Nguyen, Young-il Kim, Joao A. de Andrade, Tracy Luckhardt, Vincent G. Valentine, Daniel J. Kass, Steven R. Duncan> ;Plos One. 2019 Oct 4
• 70 citations
  Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis
  Camille M. Moore, Rachel Z. Blumhagen, Ivana V. Yang, Avram D Walts, Julie Powers, Tarik Walker, Makenna Bishop, Pamela Russell, Brian Vestal, Jonathan Cardwell, Chery...> ;American Journal of Respiratory and Critical Care Medicine. 2019 Jul 15
• 37 citations
  Patient Registries in Idiopathic Pulmonary Fibrosis
  Daniel A. Culver, Jürgen Behr, John A. Belperio, Tamera J. Corte, Joao A. de Andrade, Kevin R. Flaherty, Mridu Gulati, Tristan J. Huie, Lisa Lancaster, Jesse Roman, Ch...> ;American Journal of Respiratory and Critical Care Medicine. 2019 Jul 15
• 22 citations
  Home-Based Pulmonary Rehabilitation for Patients With Idiopathic Pulmonary Fibrosis: A PILOT STUDY.
  Hon K. Yuen, John D. Lowman, Robert A. Oster, Joao A. de Andrade> ;Journal of Cardiopulmonary Rehabilitation and Prevention. 2019 Jul 1
• 27 citations
  Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
  Jarrod W. Barnes, Dawn Duncan, Scott Helton, Samuel B. Hutcheson, Deepali Kurundkar, Naomi J. Logsdon, Morgan L. Locy, Jaleesa M. Garth, R. Denson, Carol Farver, Hai T...> ;American Journal of Physiology. Lung Cellular and Molecular Physiology. 2019 May 1
• 9 citations
  Predicting Outcome in Idiopathic Pulmonary Fibrosis: Addition of Fibrotic Score at Thin-Section CT of the Chest to Gender, Age, and Physiology Score Improves the Predi...
  Anurag Chahal, Roozbeh Sharif, Jubal R. Watts, Joao A. de Andrade, Tracy Luckhardt, Young-il Kim, Rekha Ramchandran, Sushilkumar K. Sonavane> ;Radiology. Cardiothoracic Imaging. 2019 Jun 27
• 45 citations
  Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: Insights from the IPF-PRO Registry
  Laurie D. Snyder, Megan L. Neely, Anne S. Hellkamp, Emily C. O'Brien, Joao Alberto de Andrade, Craig S Conoscenti, Thomas Leonard, Shaun Bender, Mridu Gulati, Daniel A...> ;Respiratory Research. 2019 May 30
• 54 citations
  Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence
  Luca Richeldi, Francesco Varone, Miguel Bergna, Joao A. de Andrade, Jeremy A. Falk, Robert W. Hallowell, Stéphane Jouneau, Yasuhiro Kondoh, Lee E. Morrow, Winfried Ran...> ;European Respiratory Review. 2018 Dec 31
• 141 citations
  Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
  Lisa Lancaster, Joao A. de Andrade, Joseph D. Zibrak, Maria L. Padilla, Carlo Albera, Steven D. Nathan, Marlies S. Wijsenbeek, John L. Stauffer, Klaus-Uwe Kirchgaessle...> ;European Respiratory Review. 2017 Dec 31
• 1 citations
  More than meets the eye: IgG4-related disease presenting as isolated interstitial lung disease.
  Aprajita Jagpal, David R. Crowe, Joao A. de Andrade, Maria del Pilar Acosta Lara, Iris Navarro-Millán> ;Rheumatology. 2017 Sep 1
• 65 citations
  Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis.
  Fu Jun Li, Ranu Surolia, Huashi Li, Zheng Wang, Tejaswini Kulkarni, Gang Liu, Joao A. de Andrade, Daniel J. Kass, Victor J. Thannickal, Steven R. Duncan, Veena B. Antony> ;Journal of Immunology. 2017 Jul 28
• Join now to see all

Journal Articles

• Oxidative Modifications of Protein Tyrosyl Residues are Increased in Plasma of Human Subjects with Interstitial Lung Disease  
  Pennathur S, Vivekanandan-Giri A, Locy ML, Kulkarni T, Zhi D, Zeng L, Byun J, de Andrade J, Thannickal VJ, Am J Respir Crit Care Med, 1/17/2015
• The Idiopathic Pulmonary Fibrosis Clinical Research Network: Diagnostic and Adjudication Processes  
  de Andrade J, Schwarz M, Collard HR, Gentry-Bumpass T, Colby T, Lynch D, Kaner R; IPFnet Investigators, Chest, 1/1/2015
• Pleiotropic Effect of the Proton Pump Inhibitor Esomeprazole Leading to Suppression of Lung Inflammation and Fibrosis  
  Ghebremarian YT, Cooke JP, Gerhart W, Griego C, Brower J, Doyle-Eisele M, Moeller BC, Zhou Q, Ho L, de Andrade J, Raghu G, Peterson L, Rivera A, Rosen GD, J Transl Med, 1/1/2015
• Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis  
  Idiopathic Pulmonary Fibrosis Clinical Research Network, Martinez FJ, de Andrade J, Anstrom KJ, King TE Jr, Raghu G, N Engl J Med, 1/29/2014
• Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis  
  Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi..., N Engl J Med, 1/29/2014
• Development and Maintenance of a Biospecimen Repository for Clinical Samples Derived from Pulmonary Patients  
  Schwiebert LM, Estell K, Meadows T, Thannickal VJ, Rowe SM, Sorscher EJ, Harris WT, Gaggar A, Dransfield M, de Andrade J., Clinical and Translational Science, 1/1/2014
• A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis  
  King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sa..., N Engl J Med, 1/1/2014
• Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease-related Intersti...  
  Saketkoo LA, Mittoo S, Frankel S, LeSage D, Sarver C, Phillips K, Strand V, Matteson EL; OMERACT Connective Tissue Disease-Interstitial Lung Diseases Working Group, J Rheumatol, 1/1/2014
• Connective Tissue Disease Related Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: Provisional Core Sets of Domains and Instruments for Use in Clinical Tr...  
  Saketkoo LA, Mittoo S, Huscher D, Khanna D, Dellaripa PF, Distler O, Flaherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Bielecka OM, LeSage D, Merkel PA, Ph..., Thorax, 1/1/2014
• Treatment of Idiopathic Pulmonary Fibrosis with Ambrisentan: A Parallel, Randomized Trial  
  Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Nathan SD, Wells AU, Collard HR, Costabel U, Richeldi L, de Andrade J, Khalil N, Morrison LD, L..., Ann Intern Med, 1/1/2013
• Disparities in Lung Transplantation before and after Introduction of the Lung Allocation Score  
  Wille KM, Harrington KF, de Andrade J, Vishin S, Oster RA, Kaslow RA, J Heart Lung Transplant, 1/1/2013
• Macitentan for the Treatment of Idiopathic Pulmonary Fibrosis: The Randomized Controlled MUSIC Trial  
  Raghu G, Million-Rousseau R, Morganti A, Perchenet L, Behr J; MUSIC Study Group, Eur Respir J, 1/1/2013
• A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis  
  Noth I, Anstrom KJ, Calvert SB, de Andrade J, Flaherty KR, Glazer C, et al., Am J Respir Crit Care Med, 1/1/2012
• Idiopathic Pulmonary Fibrosis  
  Zolak JS, de Andrade J, Immunol Allergy Clin N Am, 1/1/2012
• Prednisone, Azathioprine, and N-acetylcysteine for Pulmonary Fibrosis  
  Idiopathic Pulmonary Fibrosis Clinical Research Network, Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ, N Engl J Med, 1/1/2012
• Acute Exacerbations of Interstitial Lung Disease  
  Hajari AS, de Andrade J, Clinical Pulmonary Medicine, 1/1/2011
• Innovative Approaches to the Therapy of Fibrosis  
  de Andrade J, Thannickal VJ, Current Opinion in Rheumatology, 1/1/2009
• Effect of Interferon Gamma 1b on Survival in Patients with Idiopathic Pulmonary Fibrosis (INSPIRE): A Multicentre, Randomized, Placebo-controlled Trial  
  King TE Jr, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Shan SA, Szwarcberg J, Thomeer M, Valeyre D, du Bois RM; INSPIRE Study Group, Lancet, 1/1/2009
• BUILD-1: A Randomized Placebo-Controlled Trial of Bosentan in Patients with Idiopathic Pulmonary Fibrosis  
  King, Jr TE, Behr J, Brown KK, du Bois RM, Lancaster L, de Andrade J, Stahler G, Leconte I, Roux S, Raghu G, American Journal of Respiratory and Critical Care Medicine, 1/1/2008
• Association of Protein C and Type-1 Plasminogen Activator Inhibitor with Primary Graft Disfunction  
  Christie JD, Robinson N, Ware LB, Plotnick M, de Andrade J, Lama V, Milstone A, Orens J, Weinacker A, Demissie E, Bellamy S, Kawut SM for the Lung Transplant Outcomes ..., American Journal of Respiratory and Critical Care Medicine, 1/1/2007
• Thoughts on the Diagnosis and Management of Interstitial Lung Diseases  
  de Andrade J., Southern Medical Journal, 1/1/2007
• Plasma Intercellular Adhesion Molecule-1 and Von Willebrand Factor in Primary Graft Dysfunction After Lung Transplantation  
  Covarrubias M, Ware LB, Kawut SM, de Andrade J, Milstone A, Weinacker A, Orens J, Lama V, Wille K, Bellamy S, Shah C, Demissie E, Christie JD, for the Lung Transplant ..., American Journal of Transplantation, 1/1/2007
• Reactive Nitrogen Species and Myeloperoxidase Correlate with Clinical Markers of Airway Inflammation in Lung Transplant Recipients  
  de Andrade J, Christie JD, Young Jr KR, McGiffin D, Zorn G, Alexander BD, Jackson RM, Journal of Investigative Medicine, 1/1/2001
• Protein Nitration, Metabolites of Reactive Nitrogen Species and Inflammation in Lung Allografts  
  de Andrade J, Crow JP, Viera L, Alexander CB, Young KR, McGiffin DC, Zorn GL, Zhu S, Matalon S, Jackson RM, American Journal of Respiratory and Critical Care Medicine, 1/1/2000
• The Lung in Systemic Lupus Erythematosus  
  de Andrade J, Kennedy JI, Seminars in Respiratory and Critical Care Medicine, 1/1/1999
• Join now to see all

Books/Book Chapters

• Interstitial Lung Disease 
  Chapter: Coagulation and Fibrinolysis in Lung Injury and Repair 
  de Andrade J, Olman MAEditors: Schwarz MI, King TE.People's Medical Publishing House, Shelton, CTEdition 5th,2011
• Cecil Review of Internal Medicine 
  Chapter: Pulmonary Diseases 
  de Andrade JEditors: Cooper JAD, Pappas PG.Elsevier2004
• Cancer-Integracao Clinico-Biologica 
  Chapter: O PDQ (Physician Data Query), um Sistema na Difusao de Formas Correntes e Experimentais para o Tratamento do Câncer 
  Robin H, Vinholes J, Machado V, de Andrade J.Editors: Fleck J.Artes Medicas1992

Abstracts/Posters

• Establishing a Standard of Care for Patients with Idiopathic Pulmonary Fibrosis - Concept of "bundle of Care".
  Kulkarni T, Willoughby J, Kim Y, Ramachandran R, Luckhardt T, de Andrade J., Am J Respir Crit Care Med, 1/1/2015
• Next Generation Sequencing Does Not Support a Causative Role for Herpes Virus in IPF
  Lasky J, Yin Q, Flemington E, Zhu D, Kaminski N, de Andrade J, Pulmonary Fibrosis Summit, Washington DC, 1/1/2015
• A Bundle of Care Improves Outcomes in Idiopathic Pulmonary Fibrosis
  Kulkarni T, Acosta Lara P, Willoughby J, Kim Y, Ramachandran R, Alexander CB, Luckhardt T, Thannickal VJ, de Andrade J, Pulmonary Fibrosis Summit, Washington DC, 1/1/2015
• Clinical Characteristics and Disease Burden of Newly Diagnosed IPF at Tertiary Care Centers: Initial Results from the Idiopathic Pulmonary Fibrosis-PROspective Outcome...
  Durheim M, O'Brien E, Gamerman V, Shrader P, Todd JL, Snyder L, Anstrom K, Belperio J, Culver D, de Andrade J, Roman J, Whelan TP, Palmer S, Conoscenti C, Pulmonary Fibrosis Summit, Washington DC, 1/1/2015
• Safety and Efficacy of Anti-CTGF Monoclonal Antibody Fg-3019 for Treatment of Idiopathic Pulmonary Fibrosis: Results of a Phase 2 Clinical Trials Two Years after Initi...
  Raghu G, Scholand M, de Andrade J, Lancaster L, Mageto YM, Goldin JG, Porter S, Neff TB, Valone F, Stauffer J., Am J Respir Crit Care Med, 1/1/2014
• Short Term Outcomes of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis
  Sharma N, Bhatt S, Luckhardt T, de Andrade J., Chest, 1/1/2014
• Therapeutic Targeting If Src Kinase and Myofibroblast Activation in Pulmonary Fibrosis
  Ding Q, Cai GQ, Hu M, Antony VB, Liu G, de Andrade J, Luckhardt T, Liu RM, Zhou Y, Thannickal VJ, Am J Respir Crit Care Med, 1/1/2012
• Testing a Simplified High Resolution CT scan of the Chest (HRCT) Classification as Predictor of Outcomes in Patients with Interstitial Lung Disease
  de Andrade J, Harrington K, Alexander CB, Singh SP, Sanders C, Nath H, American Journal of Respiratory and Critical Care Medicine, 1/1/2010
• Transplant Outcomes in Patients with Connective Tissue Disorders
  Hajari A, Wille K, de Andrade J, Harrington K, Chest, 1/1/2009
• Racial Disparities in Idiopathic Pulmonary Fibrosis: Data from a Southeastern U.S. Center
  de Andrade J, Daniel ND, Wille KM, Gerald LB, Harrington KF, Proceedings of the American Thoracic Society, 1/1/2008
• Combination Therapy Utilizing Azithromycin And Photopheresis for Bronchiolitis Obliterans Syndrome After Lung Transplantation
  Hajari A, Leon K, Gaggar A, de Andrade J, Barney J, Pajaro O, George J, Kirklin J, McGiffin D, Young KR, Marques M, Wille K, American College of Chest Physicians, Chest, Chicago, IL, 1/1/2007
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Iloprost Inhalation in Adults with Abnormal Pulmonary Arterial Pressure and...
  Krowka MJ, Ahmad S, de Andrade J, et al., Chest, 1/1/2007
• Plasma Intercellular Adhesion Molecule-1 (ICAM) and von Willebrand Factor (VWF) in Primary Graft Dysfunction Following Lung Transplantation
  Covarrubias MB, Ware LB, Kawut J, de Andrade J, Milstone A, Weinacker A, Orens J, Lama V, Christie JD, Proceedings of the American Thoracic Society, 1/1/2006
• Donor Gluthatione S-Transferase mu Null Genotype is Independently Associated with Primary Graft Dysfunction Following Lung Transplantation
  Christie JD, Aplenc R, de Andrade J, Lama V, Milstone A, DeMissie E, Ware L, Weinacker A, Kawut, the Lung Transplant Outcomes Group, Proceedings of the American Thoracic Society, 1/1/2006
• Early Elevation of Plasma PAI-1 Levels Is Associated with Severe Primary Graft Dysfunction at 72 Hours after Lung Transplantation
  Christie JD, Robinson N, Plotnick M, de Andrade J, Kawut S, Milstone A, Weinacker A, Ware L, for the Lung Transplant Outcomes Group, Proceedings of the American Thoracic Society, 1/1/2005
• Donor Glutathione S-Transferase Genotype is Associated with Primary Graft Dysfunction Following Lung Transplantation
  Christie JD, Aplenc R, de Andrade J, Kawut S, Milstone A, Weinacker A, Zhou L, Mazzotta J, DeMissie, Ely EW, Journal of Heart and Lung Transplantation, 1/1/2005
• Reactive Nitrogen Species, Airway Inflammation and Fibrosis in Lung Transplant
  de Andrade J, Crow J, Viera L, Alexander CB, Young KR, McGiffin D, Zorn G, Matalon S, Jackson R, Chest, 1/1/2001
• Reactive Nitrogen Correlate with Airway Inflammation in Lung Transplants
  de Andrade J, Young KR, McGiffin D, Zorn G, Alexander CB, Christie JD, Jackson R, ALA/ATS International Conference, American Journal of Respiratory and Critical Care Medicine, Toronto, ON, Canada, 1/1/2000
• Reactive Nitrogen Species in Human Allografts and Clinical Correlates
  de Andrade J, Alexander CB, Young KR, McGiffin D, Zorn G, Beckman J, Matalon S, Zhu S, Jackson RM, European Respiratory Society 1999 Annual Congress, European Respiratory Journal, Madrid, Spain, 1/1/1999
• Protein Nitration and Chlorination in Human Lung Allografts
  Jackson R, Ohman T, Helton E, Crow JP, Viera L, Alexander CB, Young KR, McGiffin D, Zorn G, de Andrade J, Beckman J, Matalon S, ALA/ATS International Conference, American Journal of Respiratory and Critical Care Medicine, San Diego, California, 1/1/1999
• Helical Chest Computed Tomography in the Evaluation of Acute Pulmonary Thromboembolism: An Outcome Study
  Ball JA, Inampudi C, de Andrade J, Nath H, Olman MA, ATS/ALA International Conference, American Journal of Respiratory and Critical Care Medicine, Chicago, Illinois, 1/1/1998
• Histological Diagnosis of Bronchogenic Carcinoma. The Role of Sputum Cytology
  Henn LA, de Andrade J, et al., Abstracts of the XXVI Brazilian Congress of Pulmonology. Jornal de Pneumologia, 1/1/1992
• Air Pollution and Public Health. Comparative Study of Two Cities of the Coal Mining Zone of Rio Grande do Sul
  Andrade PP, de Andrade J, Rigatto M, Abstracts of the XXIV Brazilian Congress of Pulmonology. Jornal de Pneumologia, 1/1/1988
• Join now to see all

Lectures

• Idiopathic Pulmonary Fibrosis 
  1/1/2015
• Non-pharmacological management of Idiopathic Pulmonary Fibrosis 
  Montreal, QC, Canada - 1/1/2015
• Clinical Aspects of Other Interstitial Lung Diseases (Non-granulomatous) 
  1/1/2011
• Therapies to Prevent or Treat Acute Exacerbations of Idiopathic Pulmonary Fibrosis 
  1/1/2011
• Idiopathic Pulmonary Fibrosis Clinical Trials: Can We Agree on the Endpoints? 
  1/1/2011
• General Approach to Interstitial Lung Diseases - Case Discussion 
  UAB Department of Medicine - 1/1/2010
• Clinical Aspects of Idiopathic Pulmonary Fibrosis 
  1/1/2010
• The Natural History of IPF: What We Have Learned From Clinical Trials 
  1/1/2010
• Is this Idiopathic Pulmonary Fibrosis? Cases from the Adjudication Committee of the NIH IPFnet 
  1/1/2010
• Acute Exacerbations of ILD and Acute Interstitial Pneumonitis 
  1/1/2010
• Caring for the Patient with Advanced IPF - Review of The (Lack Of) Evidence 
  UAB - 1/1/2009
• Caring for the Patient with Advanced IPF: Review of the Evidence 
  1/1/2009
• Bronchoscopy Should Be Utilized in the Evaluation of the Patient Suspected of Having Acute Exacerbation of Interstitial Disease 
  1/1/2009
• Important Questions in Idiopathic Pulmonary Fibrosis 
  1/1/2008
• Guess Who Is Paying for Lunch: A Critical Look at Our Relationships with the Pharmaceutical Industry 
  1/1/2008
• Interstitial Lung Diseases related to Connective Tissue Disorders 
  1/1/2007
• Who Is Paying for Lunch? A Critical Review of Our Relationships with the Pharmaceutical Industry 
  UAB - 1/1/2007
• 42 Years Old Male with Cavitary Lung Lesion 
  1/1/2007
• General Approach to Interstitial Lung Diseases 
  UAB Department of Medicine - 1/1/2006
• Overview of Interstitial Lung Diseases 
  UAB Department of Medicine - 1/1/2005
• It's a Granuloma! 
  UAB - 1/1/2005
• Hemodynamic Monitoring 
  UAB Department of Medicine - 1/1/2004
• Update on Idiopathic Pulmonary Fibrosis 
  UAB - 1/1/2004
• Inhalation Lung Diseases and other Disease Processes Producing an Interstitial Pattern on Chest X-Ray 
  University of Alabama School of Medicine - 1/1/2003
• On Pigs, Stalin, The Spanish Fall of 1918 and the S.A.R.S. Epidemics 
  UAB - 1/1/2003
• Join now to see all